ARCHIVES

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

This article is from The Cancer Letter archive.

Vol. 23 No. 20 | May 23, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

ACS Ask Stronger Federal Action Against Cigarettes

November 23, 1979

NCI Has Congressional Mandate Fr Planning Clinical Trials of Unconventional Therapies, Chabner Says

June 5, 1992

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

June 17, 1988

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984

Opening Shots Fired In 10 Year Defense of Cancer Program, Launching Of Effort To Continue, Expand It

September 19, 1980